Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 18
- Industry Trends
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis pioneers onto the London Stock Exchange face collapse.
- Press releases
High Tide Opens First European Retail Location in Berlin
High Tide Inc. (Nasdaq: HITI) has opened its first international Canna Cabana store in Berlin, Germany, marking the cannabis retailer’s initial brick-and-mortar expansion outside North America.
- Clinical Research
Ananda Exits Landmark NHS-Funded Epilepsy Trial and Public Markets
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping away from a flagship UK clinical trial into epilepsy.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 2
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
- Hemp Industry
UK Court Throws Out CBD Case Over Improper Testing, but Operators ‘More Vulnerable Than Ever’
A UK Crown Court has thrown out criminal charges against CBD hemp flower importers after ruling that police mishandled evidence and used improper testing methods, but only after a five-and-a-half-year ordeal that destroyed the defendants’ businesses and forced them to relocate abroad.
- Industry Trends
Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to ban prescriptions being sent via mail, a mixed outcome that offers both relief and concern for an industry bracing for regulatory tightening.
- Cultivation
There’s No UK Cannabis Industry Without UK Cultivation
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in the same direction.
- Clinical Research
EU ‘Intoxicating Hemp’ Review Highlights Major Knowledge Gaps Behind Blanket Bans
Last week, the US government voted to impose a blanket ban on all so-called ‘intoxicating hemp’ substances, ending what has been a contentious and long-running battle to regulate the recent emergence of THC substitutes.
- CBD Market
Trump Ends Intoxicating Hemp Era, But Unintended Victims and Repeal Efforts Signal Turbulent Year Ahead
The sweeping redefinition of ‘hemp’ in the US following the passage of the funding bill threatens non-intoxicating CBD processors while pushing consumers toward unregulated markets President Donald Trump signed legislation on November 12 that brought the longest government shutdown in history to an end.
- Investment & Finance
Real Estate, Banking, and Bankruptcy: Q3 Hits the Three Tiers of Cannabis Capital Very Differently
The story of the cannabis sector’s financial health is increasingly split between those providing the capital and those who desperately need it.
- Medical Cannabis
Patients Make History at First Educational Event on Cannabis-Based Medicines in London
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on cannabis-based medicines, hosted at the Charterhouse.
